SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Brander who wrote (2914)3/22/1998 12:25:00 PM
From: Hank  Read Replies (1) of 7041
 
Didn't I already make that point previously regarding the variability in patient to patient response to prescription drugs? Wasn't it my explanation for why there are several versions of antidepressants with the same mechanism of action? Simply stating that there is a need for more than one ED drug on the market does not automatically qualify Vasomax for approval. You said you had no opinion one way or the on the probability of Vasomax being approved in the US but it would appear that your function here is to cheer lead. Sorry for the skepticism but I fail to see why someone with no position in this stock feels compelled to stay on top of everything that is said here.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext